p-Tolylhydrazine hydrochloride, 98%, Thermo Scientific Chemicals
p-Tolylhydrazine hydrochloride, 98%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

p-Tolylhydrazine hydrochloride, 98%, Thermo Scientific Chemicals

Have Questions?
Change viewbuttonViewtableView
Quantity:
5 g
25 g
100 g
Catalog number A14220.06
also known as A14220-06
Price (USD)/ Each
52.90
-
Add to cart
Quantity:
5 g
Request bulk or custom format
Price (USD)/ Each
52.90
Add to cart
p-Tolylhydrazine hydrochloride, 98%, Thermo Scientific Chemicals
Catalog numberA14220.06
Price (USD)/ Each
52.90
-
Add to cart
Chemical Identifiers
CAS637-60-5
IUPAC Namehydrogen (4-methylphenyl)hydrazine chloride
Molecular FormulaC7H11ClN2
InChI KeyHMHWNJGOHUYVMD-UHFFFAOYSA-N
SMILES[H+].[Cl-].CC1=CC=C(NN)C=C1
View more
SpecificationsSpecification SheetSpecification Sheet
FormPowder
Assay (Titration ex Chloride)>97.5 to <102.5%
Assay (Freebase GC)>97.5%
Appearance (Color)White to pale brown
p-Tolylhydrazine hydrochloride is used as anti-cancer potential for novel anticancer drugs.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
p-Tolylhydrazine hydrochloride is used as anti-cancer potential for novel anticancer drugs.

Solubility
Soluble in water, methanol and dimethyl sulfoxide.

Notes
Store in cool, dry place in tightly closed containers. With good ventilation. Store away from oxidizing agent.
RUO – Research Use Only

General References:

  1. B Toth; and D Nagel. Studies of the tumorigenic potential of 4-substituted phenylhydrazines by the subcutaneous route. Journal of Toxicology and Environmental Health, Part A. 1981, 8 (1-2), 1-9.
  2. B. Toth; A. Tompa; K. Patill. Tumorigenic effect of 4-methylphenylhydrazine hydrochloride in Swiss mice. Zeitschrift für Krebsforschung und Klinische Onkologie. 1977, 89 (3), 245-252.